1. Home
  2. AUTL vs CLDT Comparison

AUTL vs CLDT Comparison

Compare AUTL & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$2.43

Market Cap

532.3M

Sector

Health Care

ML Signal

HOLD

Logo Chatham Lodging Trust (REIT) of Beneficial Interest

CLDT

Chatham Lodging Trust (REIT) of Beneficial Interest

HOLD

Current Price

$13.82

Market Cap

597.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUTL
CLDT
Founded
2014
2009
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
532.3M
597.5M
IPO Year
2025
2009

Fundamental Metrics

Financial Performance
Metric
AUTL
CLDT
Price
$2.43
$13.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$8.50
$11.00
AVG Volume (30 Days)
3.3M
281.5K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
4.13%
EPS Growth
N/A
275.00
EPS
N/A
N/A
Revenue
$10,120,000.00
$295,075,000.00
Revenue This Year
$80.32
$2.94
Revenue Next Year
$53.96
N/A
P/E Ratio
N/A
$610.21
Revenue Growth
496.00
N/A
52 Week Low
$1.18
$6.08
52 Week High
$2.58
$13.89

Technical Indicators

Market Signals
Indicator
AUTL
CLDT
Relative Strength Index (RSI) 64.81 66.49
Support Level $1.32 $6.62
Resistance Level $2.43 N/A
Average True Range (ATR) 0.17 0.32
MACD 0.02 0.09
Stochastic Oscillator 73.32 100.00

Price Performance

Historical Comparison
AUTL
CLDT

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.

Share on Social Networks: